Allakos Inc

ALLK11 Dec 2024
Healthcare
$1.16
-0.06 (-6.09%)
Lowest Today
$1.06
Highest Today
$1.18
Today’s Open
$1.16
Prev. Close
$1.15
52 Week High
$3.41
52 Week Low
$0.54
To Invest in Allakos Inc

Allakos Inc

Healthcare
ALLK11 Dec 2024
-0.06 (-6.09%)
1M
3M
6M
1Y
5Y
Low
$1.06
Day’s Range
High
$1.18
1.06
52 Week Low
$0.54
52-Week Range
52 Week High
$3.4
0.54
1 Day
-
1 Week
-3.11%
1 month return
-27.09%
3 month return
+81.48%
6 month return
-15.5%
1 Year return
-63.66%
3 Years return
-98.59%
5 Years return
-99.1%
10 Years return
-
Institutional Holdings
Bvf Inc
18.53
NEA Management Company, LLC
6.88
FMR Inc
6.01
Deep Track Capital, LP
5.6
Fidelity Advisor Biotechnology I
5.44
Vanguard Group Inc
3.93
Redmile Group, LLC
3.44

Market Status

Fundamentals
Market Cap
102.75 mln
PB Ratio
1.35
PE Ratio
0
Enterprise Value
44.56 mln
Total Assets
243.61 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Organisation
Allakos Inc
Employees
131
Industry
Biotechnology
CEO
Dr. Robert  Alexander Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step